Regis Technologies Inc.
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help expedite drugs to market. We offer unrivaled expertise in synthesis, analytical and separation services to scale your active pharmaceutical ingredients (API) from initial process development to validation and commercial manufacturing. From our extensive organic chemistry expertise and collegiate collaborations, we can deliver the added value of our innovative, proprietary chromatography products, especially those with a chiral emphasis. We continue to offer fine organic chemicals as we have for the past 59 years. Consider Regis an important partner in your drug development processes. We thrive on the challenges that these projects bring.
Regis Technologies, Inc., partners with pharmaceutical and biotechnology companies to help expedite drugs to market. We offer expertise in synthesis, analytical and separation services to advance your active pharmaceutical ingredient (API) from initial process development and scale-up development, to final validation and commercial manufacturing. From our extensive organic expertise and collegiate collaborations, we can deliver the added value of our innovative, proprietary chromatography products, especially those with a chiral emphasis. And, we continue to offer fine organic chemicals as we have for 59 years.
- GMP Manufacturing Services
Regis Technologies partners with its customers to produce Active Pharmaceutical Ingredients (APIs) and intermediates. We have manufactured high value intermediates and APIs under GMP for over 20 years. This service can advance projects from initial process development, scale-up development through final validation and commercial manufacturing. RegisSEP™ SFC Separations Services, a superior separations technology that uses environmentally friendly carbon dioxide, is our most recent addition to our synthesis services.
- Chromatography Products
Regis Technologies is a leading manufacturer of chromatography products, especially those with a chiral emphasis. We offer our proprietary Chiral Stationary Phases and HPLC columns as well as IAM Drug Discovery Columns, RAM and ISRP Direct Injection Columns, Ion Pairing Reagents and Buffers, and GC Derivatization Reagents. Our SFC separations service is an exciting addition to these capabilities.
- Pharmaceutical Services
In-house expert Analytical Method Development services including: HPLC (chiral and achiral), LC/MS and GC methods, stability indicating methods and method validations. In-house Quality Control services including: API release, Reference Standard Characterization, Structure Elucidation, and ICH compliant stability.
- Fine Chemicals
Regis Technologies manufactures a small portfolio of high purity fine organic chemicals according to controlled manufacturing procedures for over 58 years.
Located in Morton Grove, a suburb of Chicago, Regis Technologies, Inc., is a privately held company founded in 1956 and operated by the Glunz family. Regis continually updates and maintains a modern 36,000 square foot facility. Regis became a fully compliant GMP organization in 1993. By 2002, Regis expanded and improved every lab and manufacturing area. This included a new production facility with six dedicated reactor suites, individual kilo lab suites, an expanded quality control department and the installation of a cryogenic reactor. In 2009, we built a multi-million dollar Quality Control Laboratory and dedicated NMR room.
Celebrating Over 50 Years of Service
Regis Technologies, Inc. is proud to have a rich history in serving the life science industry. Since its opening in 1956, Regis has earned a worldwide reputation for excellence in chromatography products and its capability to synthesize complex molecules for the pharmaceutical industry. Few companies can claim this long standing history of success and innovation while continuing to grow into the future.
As an innovator, Regis initially concentrated on custom synthetic chemistry for the emerging field of psychopharmacology. Later it moved into gas and liquid chromatography, and more recently developed expertise in synthesizing drugs for all stages of drug development. Today, Regis serves startup biotechnology companies and large, multinational pharmaceutical corporations helping to expedite new drugs to market.
Regis Technologies, Inc. continues to enjoy growth by providing expanded services for drug development, including process research, analytical method development, scale-up, validation, stability studies, and commercialization. Additionally, we are expanding our chromatographic separation capability by adding Super Critical Fluid Chromatography (SCF), an environmentally friendly technology. Now, with a dedicated staff and a new Synthetic Research Laboratory wing, Regis continues to broaden its capacity to serve the pharmaceutical industry.